Germany Infectious Disease Market Outlook to 2025

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4995
Buy Report

Published: March 30, 2020 Report Code: GDMECC4906DB-ST

Select Item

GlobalData’s “Germany Infectious Disease Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Germany Infectious Disease market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Chlamydia Trachomatis Tests, Clostridium difficile Tests, Cytomegalovirus (CMV) Tests, Hepatitis Tests, Human Immunodeficiency Virus (HIV) Tests, Human Papilloma Virus (HPV) Tests, Human T-Lymphotropic Virus (HTLV) Tests, Multi-parameter Chlamydia Trachomatis and Neisseria Gonorrhoeae NAATs, Multi-parameter HIV, Hepatitis B, and Hepatitis C Nucleic Acid Amplification Tests (NAATs), Mycobacterium Tuberculosis Tests, Neisseria Gonorrhoeae Tests and Treponema pallidum Tests.

The Germany Infectious Disease Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2018 company share and distribution share data for Infectious Disease Market.
• Global corporate-level profiles of key companies operating within the Germany Infectious Disease Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Germany Infectious Disease Tests is segmented as follows:

• Chlamydia Trachomatis Tests

• Clostridium difficile Tests

• Cytomegalovirus (CMV) Tests

• Hepatitis Tests

• Human Immunodeficiency Virus (HIV) Tests

• Human Papilloma Virus (HPV) Tests

• Human T-Lymphotropic Virus (HTLV) Tests

• Multi-parameter Chlamydia Trachomatis and Neisseria Gonorrhoeae NAATs

• Multi-parameter HIV, Hepatitis B, and Hepatitis C Nucleic Acid Amplification Tests (NAATs)

• Mycobacterium Tuberculosis Tests

• Neisseria Gonorrhoeae Tests

• Treponema pallidum Tests

Reasons to Buy

Key Reasons to Purchase – The Germany Infectious Disease Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “Germany Infectious Disease Market Outlook to 2025” report:
• Abbott Laboratories
• Siemens Healthineers AG
• F. Hoffmann-La Roche Ltd

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 What Is This Report About? 6

2.2 Infectious Disease Market Segmentation 6

2.3 Definitions of Markets Covered in the Report 8

3 Infectious Disease Market, Germany 15

3.1 Infectious Disease Market, Germany, Revenue ($m), 2015-2025 15

3.1.1 Chlamydia Trachomatis Tests Market, Germany, Revenue ($m), by Segment, 2015-2025 18

3.1.2 Clostridium difficile Tests Market, Germany, Revenue ($m), by Segment, 2015-2025 20

3.1.3 Cytomegalovirus (CMV) Tests Market, Germany, Revenue ($m), by Segment, 2015-2025 23

3.1.4 Hepatitis Tests Market, Germany, Revenue ($m), by Segment, 2015-2025 25

3.1.5 Human Immunodeficiency Virus (HIV) Tests Market, Germany, Revenue ($m), by Segment, 2015-2025 27

3.1.6 Human Papilloma Virus (HPV) Tests Market, Germany, Revenue ($m), by Segment, 2015-2025 30

3.1.7 Human T-Lymphotropic Virus (HTLV) Tests Market, Germany, Revenue ($m), by Segment, 2015-2025 32

3.1.8 Mycobacterium Tuberculosis Tests Market, Germany, Revenue ($m), by Segment, 2015-2025 34

3.1.9 Neisseria Gonorrhoeae Tests Market, Germany, Revenue ($m), by Segment, 2015-2025 36

3.1.10 Treponema pallidum Tests Market, Germany, Revenue ($m), by Segment, 2015-2025 38

3.2 Infectious Disease Market, Germany, Volume (Units), 2015-2025 41

3.2.1 Chlamydia Trachomatis Tests Market, Germany, Volume (Units), by Segment, 2015-2025 46

3.2.2 Clostridium difficile Tests Market, Germany, Volume (Units), by Segment, 2015-2025 48

3.2.3 Cytomegalovirus (CMV) Tests Market, Germany, Volume (Units), by Segment, 2015-2025 51

3.2.4 Hepatitis Tests Market, Germany, Volume (Units), by Segment, 2015-2025 53

3.2.5 Human Immunodeficiency Virus (HIV) Tests Market, Germany, Volume (Units), by Segment, 2015-2025 55

3.2.6 Human Papilloma Virus (HPV) Tests Market, Germany, Volume (Units), by Segment, 2015-2025 58

3.2.7 Human T-Lymphotropic Virus (HTLV) Tests Market, Germany, Volume (Units), by Segment, 2015-2025 60

3.2.8 Mycobacterium Tuberculosis Tests Market, Germany, Volume (Units), by Segment, 2015-2025 62

3.2.9 Neisseria Gonorrhoeae Tests Market, Germany, Volume (Units), by Segment, 2015-2025 64

3.2.10 Treponema pallidum Tests Market, Germany, Volume (Units), by Segment, 2015-2025 66

3.3 Infectious Disease Market, Germany, Average Price ($), 2015-2025 69

3.4 Infectious Disease Market, Germany, Distribution Share by Revenue ($m), 2018 75

3.5 Infectious Disease Market, Germany, Company Share by Revenue ($m), 2018 76

4 Overview of Key Companies in Germany, Infectious Disease Market 78

4.1 Abbott Laboratories 78

4.1.1 Company Overview 78

4.2 Siemens Healthineers AG 78

4.2.1 Company Overview 78

4.3 F. Hoffmann-La Roche Ltd 78

4.3.1 Company Overview 78

4.4 Qiagen NV 79

4.4.1 Company Overview 79

4.5 Hologic Inc 79

4.5.1 Company Overview 79

4.6 Danaher Corp 79

4.6.1 Company Overview 79

4.7 Becton Dickinson and Co 79

4.7.1 Company Overview 79

5 Infectious Disease Market Pipeline Products 80

6 Financial Deals Landscape 83

6.1 Acquisition 83

6.1.1 Qiagen Withdraws Plan to Sell ItSelf 83

6.2 Merger 84

6.2.1 OpGen and Curetis to Merge 84

6.3 Venture Financing 86

6.3.1 GNA Biosolutions Raises USD13.5 Million in Series C Financing 86

6.3.2 Spindiag Raises USD4.5 Million in Expanded Series A Financing 88

7 Recent Developments 89

7.1 Corporate Communications 89

7.1.1 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership 89

7.1.2 Jul 29, 2019: Changes in the Managing Board of Siemens Healthineers 89

7.1.3 May 21, 2019: Curetis to receive additional EUR

6.5 Million financing from EIB and Yorkville 90

7.1.4 Feb 21, 2019: Thomas Heydler appointed to the Supervisory Board of Eppendorf 90

7.2 Financial Announcements 90

7.2.1 Nov 14, 2019: Curetis provides business update for the first nine months of 2019 90

7.2.2 Sep 18, 2019: Curetis reports financial results for the first six months of 2019 93

7.2.3 Jul 29, 2019: Siemens Healthineers continues to drive growth forward 96

7.2.4 May 17, 2019: Curetis announces financial results for the first three months of 2019 97

7.2.5 May 02, 2019: Siemens Healthineers posts strong revenue and profit growth in the second quarter 99

7.2.6 Apr 11, 2019: Curetis publishes full-year 2018 financial results and updated guidance for 2019 100

7.2.7 Feb 28, 2019: Biocartis announces 2018 results and 2019 outlook 103

7.3 Other Significant Developments 106

7.3.1 Nov 05, 2019: Thermo Fisher Scientific highlights expanded pharma services capabilities during CPhI 106

7.3.2 Sep 16, 2019: Curetis group subsidiary Ares Genetics signs R&D and option agreement with leading Global IVD Corporation 107

7.3.3 Aug 12, 2019: Curetis retains H.C. Wainwright as strategic advisor 108

7.3.4 Jul 01, 2019: Mobidiag signs exclusive agreement with Pro Med Diagnostics for the distribution of Amplidiag and Novodiag Diagnostic Solutions in Africa 108

7.4 Product News 109

7.4.1 Mar 21, 2019: GILUPI extends patent portfolio – New US patent granted 109

7.5 Strategy And Business Planning 109

7.5.1 Aug 07, 2019: Curetis Group Company Ares Genetics launches service laboratory for NGS-based Molecular Drug Resistance Testing 109

7.5.2 May 23, 2019: QIAGEN and U.K. alliance launch APIS Assay Technologies to expand biomarker research and foster healthcare innovation 110

8 Appendix 112

8.1 Research Methodology 113

8.1.1 Coverage 113

8.1.2 Secondary Research 113

8.1.3 Primary Research 114

8.1.4 Market Modeling and Forecasting 115

8.1.5 Company Share Analysis 116

8.1.6 Distribution Share Analysis 117

8.1.7 Benchmarking 117

8.2 GlobalData Consulting 117

8.3 Contact Us 118

8.4 Disclaimer 118

Table

1.1 List of Tables

Table 1: Infectious Disease Market, Germany, Revenue ($m), USD Constant, 2015-2020 16

Table 2: Infectious Disease Market, Germany, Revenue ($m), USD Constant, 2021-2025 17

Table 3: Chlamydia Trachomatis Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 19

Table 4: Chlamydia Trachomatis Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 19

Table 5: Clostridium difficile Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 21

Table 6: Clostridium difficile Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 22

Table 7: Cytomegalovirus (CMV) Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 24

Table 8: Cytomegalovirus (CMV) Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 24

Table 9: Hepatitis Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 26

Table 10: Hepatitis Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 26

Table 11: Human Immunodeficiency Virus (HIV) Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 28

Table 12: Human Immunodeficiency Virus (HIV) Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 29

Table 13: Human Papilloma Virus (HPV) Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 31

Table 14: Human Papilloma Virus (HPV) Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 31

Table 15: Human T-Lymphotropic Virus (HTLV) Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 33

Table 16: Human T-Lymphotropic Virus (HTLV) Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 33

Table 17: Mycobacterium Tuberculosis Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 35

Table 18: Mycobacterium Tuberculosis Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 35

Table 19: Neisseria Gonorrhoeae Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 37

Table 20: Neisseria Gonorrhoeae Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 37

Table 21: Treponema pallidum Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 39

Table 22: Treponema pallidum Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 40

Table 23: Infectious Disease Market, Germany, Volume (Units), 2015-2020 42

Table 24: Infectious Disease Market, Germany, Volume (Units), 2021-2025 44

Table 25: Chlamydia Trachomatis Tests Market, Germany, Volume (Units), 2015-2020 47

Table 26: Chlamydia Trachomatis Tests Market, Germany, Volume (Units), 2021-2025 47

Table 27: Clostridium difficile Tests Market, Germany, Volume (Units), 2015-2020 49

Table 28: Clostridium difficile Tests Market, Germany, Volume (Units), 2021-2025 50

Table 29: Cytomegalovirus (CMV) Tests Market, Germany, Volume (Units), 2015-2020 52

Table 30: Cytomegalovirus (CMV) Tests Market, Germany, Volume (Units), 2021-2025 52

Table 31: Hepatitis Tests Market, Germany, Volume (Units), 2015-2020 54

Table 32: Hepatitis Tests Market, Germany, Volume (Units), 2021-2025 54

Table 33: Human Immunodeficiency Virus (HIV) Tests Market, Germany, Volume (Units), 2015-2020 56

Table 34: Human Immunodeficiency Virus (HIV) Tests Market, Germany, Volume (Units), 2021-2025 57

Table 35: Human Papilloma Virus (HPV) Tests Market, Germany, Volume (Units), 2015-2020 59

Table 36: Human Papilloma Virus (HPV) Tests Market, Germany, Volume (Units), 2021-2025 59

Table 37: Human T-Lymphotropic Virus (HTLV) Tests Market, Germany, Volume (Units), 2015-2020 61

Table 38: Human T-Lymphotropic Virus (HTLV) Tests Market, Germany, Volume (Units), 2021-2025 61

Table 39: Mycobacterium Tuberculosis Tests Market, Germany, Volume (Units), 2015-2020 63

Table 40: Mycobacterium Tuberculosis Tests Market, Germany, Volume (Units), 2021-2025 63

Table 41: Neisseria Gonorrhoeae Tests Market, Germany, Volume (Units), 2015-2020 65

Table 42: Neisseria Gonorrhoeae Tests Market, Germany, Volume (Units), 2021-2025 65

Table 43: Treponema pallidum Tests Market, Germany, Volume (Units), 2015-2020 67

Table 44: Treponema pallidum Tests Market, Germany, Volume (Units), 2021-2025 68

Table 45: Infectious Disease Market, Germany, Average Price ($), 2015-2020 69

Table 46: Infectious Disease Market, Germany, Average Price ($), 2021-2025 72

Table 47: Infectious Disease Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2018 75

Table 48: Infectious Disease Market, Germany, Company Share by Revenue ($m), USD Constant, 2018 77

Table 49: Infectious Disease Market Pipeline Products 80

Table 50: Qiagen Withdraws Plan to Sell ItSelf 83

Table 51: OpGen and Curetis to Merge 84

Table 52: GNA Biosolutions Raises USD13.5 Million in Series C Financing 86

Table 53: Spindiag Raises USD4.5 Million in Expanded Series A Financing 88

Table 54: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 115

Figures

1.2 List of Figures

Figure 1: Infectious Disease Market, Germany, Revenue ($m), USD Constant, 2015-2025 15

Figure 2: Chlamydia Trachomatis Tests Market, Germany, Revenue ($m), USD Constant, 2015-2025 18

Figure 3: Clostridium difficile Tests Market, Germany, Revenue ($m), USD Constant, 2015-2025 20

Figure 4: Cytomegalovirus (CMV) Tests Market, Germany, Revenue ($m), USD Constant, 2015-2025 23

Figure 5: Hepatitis Tests Market, Germany, Revenue ($m), USD Constant, 2015-2025 25

Figure 6: Human Immunodeficiency Virus (HIV) Tests Market, Germany, Revenue ($m), USD Constant, 2015-2025 27

Figure 7: Human Papilloma Virus (HPV) Tests Market, Germany, Revenue ($m), USD Constant, 2015-2025 30

Figure 8: Human T-Lymphotropic Virus (HTLV) Tests Market, Germany, Revenue ($m), USD Constant, 2015-2025 32

Figure 9: Mycobacterium Tuberculosis Tests Market, Germany, Revenue ($m), USD Constant, 2015-2025 34

Figure 10: Neisseria Gonorrhoeae Tests Market, Germany, Revenue ($m), USD Constant, 2015-2025 36

Figure 11: Treponema pallidum Tests Market, Germany, Revenue ($m), USD Constant, 2015-2025 38

Figure 12: Infectious Disease Market, Germany, Volume (Units), 2015-2025 41

Figure 13: Chlamydia Trachomatis Tests Market, Germany, Volume (Units), 2015-2025 46

Figure 14: Clostridium difficile Tests Market, Germany, Volume (Units), 2015-2025 48

Figure 15: Cytomegalovirus (CMV) Tests Market, Germany, Volume (Units), 2015-2025 51

Figure 16: Hepatitis Tests Market, Germany, Volume (Units), 2015-2025 53

Figure 17: Human Immunodeficiency Virus (HIV) Tests Market, Germany, Volume (Units), 2015-2025 55

Figure 18: Human Papilloma Virus (HPV) Tests Market, Germany, Volume (Units), 2015-2025 58

Figure 19: Human T-Lymphotropic Virus (HTLV) Tests Market, Germany, Volume (Units), 2015-2025 60

Figure 20: Mycobacterium Tuberculosis Tests Market, Germany, Volume (Units), 2015-2025 62

Figure 21: Neisseria Gonorrhoeae Tests Market, Germany, Volume (Units), 2015-2025 64

Figure 22: Treponema pallidum Tests Market, Germany, Volume (Units), 2015-2025 66

Figure 23: Infectious Disease Market, Germany, Company Share (%) 2018 76

Frequently asked questions

Germany Infectious Disease Market Outlook to 2025 standard reports
Currency USD
$4,995

Can be used by individual purchaser only

Most Popular
$9,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$14,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more In Vitro Diagnostics reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Germany Infectious Disease Market Outlook to 2025 in real time.

  • Access a live Germany Infectious Disease Market Outlook to 2025 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more